Total Payments
$14,840
2024 Payments
$2,076
Companies
37
Transactions
377
Medicare Patients
2,404
Medicare Billing
$210,247
Payment Breakdown by Category
Food & Beverage$9,921 (66.9%)
Consulting$4,189 (28.2%)
Education$380.40 (2.6%)
Other$350.00 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,921 | 368 | 66.9% |
| Consulting Fee | $4,189 | 2 | 28.2% |
| Education | $380.40 | 6 | 2.6% |
| Honoraria | $350.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dermavant Sciences, Inc. | $2,545 | 19 | $0 (2024) |
| PFIZER INC. | $2,526 | 7 | $0 (2023) |
| ABBVIE INC. | $1,912 | 77 | $0 (2024) |
| Galderma Laboratories, L.P. | $893.27 | 23 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $644.68 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $571.07 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $549.40 | 28 | $0 (2023) |
| Janssen Biotech, Inc. | $525.06 | 27 | $0 (2024) |
| Biofrontera Inc. | $516.61 | 5 | $0 (2024) |
| Almirall LLC | $456.83 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,076 | 92 | ABBVIE INC. ($348.57) |
| 2023 | $4,773 | 133 | Dermavant Sciences, Inc. ($2,470) |
| 2022 | $1,615 | 89 | ABBVIE INC. ($477.85) |
| 2021 | $1,295 | 34 | Galderma Laboratories, L.P. ($337.66) |
| 2020 | $176.63 | 4 | VYNE Pharmaceuticals Inc. ($159.00) |
| 2019 | $1,258 | 9 | Biofrontera Inc. ($462.52) |
| 2018 | $887.97 | 10 | Almirall LLC ($242.94) |
| 2017 | $2,758 | 6 | PFIZER INC. ($2,329) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.28 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $9.47 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.48 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Podiatry | ||||||
| 10/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $81.51 | General |
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $32.88 | General |
| Category: Immunology | ||||||
| 10/03/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $31.92 | General |
| Category: Immunology | ||||||
| 09/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,434 | 2,730 | $292,856 | $140,796 |
| 2022 | 10 | 810 | 1,267 | $113,878 | $57,271 |
| 2021 | 8 | 160 | 185 | $21,893 | $12,180 |
Total Patients
2,404
Total Services
4,182
Medicare Billing
$210,247
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 22 | 97 | $43,650 | $19,823 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 238 | 311 | $33,950 | $18,945 | 55.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 193 | 239 | $36,243 | $18,529 | 51.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 178 | $31,472 | $15,462 | 49.1% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 21 | 102 | $25,500 | $13,939 | 54.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 138 | 138 | $22,631 | $9,532 | 42.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 132 | 155 | $22,785 | $9,444 | 41.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 203 | 277 | $27,517 | $8,753 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $14,226 | $7,275 | 51.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 157 | 919 | $7,664 | $4,381 | 57.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 16 | $5,350 | $3,551 | 66.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 11 | 20 | $5,490 | $2,826 | 51.5% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 22 | 91 | $5,096 | $2,820 | 55.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 34 | 40 | $2,880 | $1,460 | 50.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 13 | 14 | $2,752 | $1,378 | 50.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 17 | 17 | $2,848 | $1,299 | 45.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $1,742 | $904.59 | 51.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 15 | $916.50 | $457.22 | 49.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 24 | $144.00 | $17.90 | 12.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 119 | $21,040 | $10,534 | 50.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 102 | 113 | $14,914 | $9,000 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 141 | $14,018 | $8,878 | 63.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $14,319 | $7,981 | 55.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 101 | 101 | $16,563 | $7,017 | 42.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 87 | 93 | $13,659 | $5,792 | 42.4% |
About Dr. Gordon Rainey, MD
Dr. Gordon Rainey, MD is a General Practice healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528046331.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gordon Rainey, MD has received a total of $14,840 in payments from pharmaceutical and medical device companies, with $2,076 received in 2024. These payments were reported across 377 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($9,921).
As a Medicare-enrolled provider, Rainey has provided services to 2,404 Medicare beneficiaries, totaling 4,182 services with total Medicare billing of $210,247. Data is available for 3 years (2021–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Other Specialties Dermatology
- Location San Antonio, TX
- Active Since 01/03/2006
- Last Updated 07/23/2020
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1528046331
Products in Payments
- VTAMA (Drug) $2,545
- EUCRISA (Drug) $2,502
- SKYRIZI (Biological) $988.46
- DUPIXENT (Biological) $694.09
- TREMFYA (Drug) $525.06
- RINVOQ (Biological) $519.40
- Sotyktu (Drug) $507.92
- COSENTYX (Biological) $376.77
- Ameluz (Drug) $350.00
- SILIQ (Drug) $313.23
- ADBRY (Biological) $298.71
- Humira (Biological) $231.27
- TALTZ (Drug) $219.00
- YCANTH (Drug) $211.24
- AMZEEQ (Drug) $190.48
- ORACEA (Drug) $171.56
- OPZELURA (Drug) $167.70
- AMELUZ (Drug) $166.61
- DAXXIFY (Drug) $164.03
- Otezla (Drug) $149.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in San Antonio
Dr. Alan Douglas, Dds, DDS
General Practice — Payments: $805,638
General Practice $805,638
Dr. Joseph Boyle, D.d.s, D.D.S
General Practice — Payments: $43,798
General Practice $43,798
Dr. Richard Zimmermann, Dds, DDS
General Practice — Payments: $14,925
General Practice $14,925
Jeffrey Rouse, D.d.s, D.D.S
General Practice — Payments: $13,974
General Practice $13,974
Dr. Woods Woolwine, D.d.s, D.D.S
General Practice — Payments: $13,632
General Practice $13,632
Dr. James Robbins, Dds, DDS
General Practice — Payments: $13,281
General Practice $13,281